ABSTRACT This review discusses recent studies on dendrimer-based nanoparticles in cancer chemotherapy and gene therapy. In order to achieve the high efficacy and low side effects of chemotherapy and gene therapy, it is essential to combine the unique features of dendrimers and the specific tumor microenvironment to target delivery and control release of therapeutic agents to tumor tissues and cells. Strategies to design the dendrimer-based delivery system in this review include non-modified dendrimers, dendrimer conjugates, assembled amphiphilic dendrimers, nanohybrid dendrimer carriers and dendrimers with inherent activity. In addition, specific functional groups on these dendrimers as stimuli-responsive system for targeting delivery and controlled release of therapeutic agents are discussed.
INTRODUCTION
Cancer has become the major diseases threatening human health [1] . Chemotherapy and gene therapy are the usual methods to combat cancer [2] [3] [4] [5] . However, the serious side effects and individually versatile therapeutic response always limit their future application [6] [7] [8] [9] . In particular, tumor microenvironment shows numerous unique properties compared with normal tissues, such as vascular abnormalities induced by the enhanced permeability and retention (EPR) effect, lower pH, anoxia, abnormal expressions of specific proteases and receptors. Therefore, it is possible to design nanomedicine as specific drug delivery systems, which are based on passive targeting, active targeting (e.g., ligand-receptor interaction) or stimuli-responsiveness to target delivery and control the release of therapeutic agents to tumor tissues and cells, which result in high efficacy and low side effects [10] [11] [12] [13] [14] .
Dendrimers are a category of synthetic macromolecules with highly branched, monodispersed and well-defined tree-like architecture. The commonly used dendrimers include poly(amidoamine) (PAMAM) [15, 16] , poly(prophylenimine) (PPI), poly(L-lysine) (PLL) [17] , triazine dendrimer [18, 19] , poly(ether imine) (PETIM) [20] [21] [22] , carbosilane dendrimer [23] , viologen dendrimer [24] , and phosphorus dendrimer [25] [26] [27] . The functional nanoparticles (NPs) can be constructed based on the unique features of dendrimers for delivery of therapeutic agents [28] [29] [30] [31] [32] [33] [34] [35] . The well-defined nanoscale size and dimensionality could be used to satisfy various applications, especially to enhance the tumor accumulation and penetration of the therapeutic agents for tumor treatment [36] [37] [38] . The abundant surface functional groups of dendrimers enable multivalent effect to enhance binding and cellular uptake by ligand/receptor recognition [39] ; the globular architecture of dendrimers can mimic proteins to avoid immunogenicity and improve biocompatibility [40] . Dendrimers with rich terminal reactive groups and excellent solubility can be easily modified with multiple ligands for specific therapies [41] . And more importantly, the interior hydrophobic cavity of dendrimers can load poor solubility drugs via noncovalent interactions, while the surface functional groups can be conjugated with drugs by covalent bond [42] [43] [44] . The cationic groups on the surface of dendrimers also can condense nucleic acids into nano-vehicle for efficient gene delivery [45, 46] . Therefore, dendrimer-based NPs 1 MOE Key Laboratory of High Performance Polymer Materials and Technology, and Department of Polymer Science & Engineering, College of with the above properties are promising delivery systems for drugs and genes.
This review will introduce new strategies based on dendrimer-based NPs in cancer chemotherapy and gene therapy. Strategies adopted in the design of dendrimerbased delivery systems in this review include non-modified dendrimers, dendrimer conjugates, assembled amphiphilic dendrimers, nanohybrid dendrimer carriers and dendrimers with inherent activity, as shown in Scheme 1. Then we will discuss how to introduce specific functional groups onto these dendrimers as stimuli-responsive system for targeting delivery and controlled release of therapeutic agents.
CHEMOTHERAPY
To overcome disadvantages of the traditional chemotherapy, dendrimer-based NPs are often utilized for drug delivery. Drugs can be encapsulated in the interior cavities or conjugated on the surface of dendrimers via covalent linkages to improve drug solubility and functionalization. In the meantime, the nanoscale structure can enhance tumor accumulation and improve penetration capability of antitumor drugs [42] [43] [44] 47, 48] .
Dendrimer-drug complexes in chemotherapy
Dendrimers contain highly branched internal cavities, which can be employed for loading hydrophobic drugs, forming dendrimer complexes to enhance their poor water solubility and enhance tumor tissue accumulation by EPR (Fig. 1a) [33, 49, 50] . To efficiently avoid the macrophage uptake and enhance accumulation in tumor tissue, dendrimer complexes modified with polyethylene glycol (PEG) linked ligands (such as PEG-folic acid, PEGiRGD and PEG-lactobionic acid) showed better antitumor effect than unmodified carriers (Fig. 1b) [51] [52] [53] . For improving drug release, dendrimer complexes with stimuli-responsive capacity can be built by introducing sensitive bonds into the dendrimer core (Fig. 1c ) [54] , or a spacer between dendrimer and shielding ligand (Fig.  1d) [55] . Besides, hydrophilic drugs also can be bonded onto the dendrimer surface to form dendrimer complexes via electrostatic interactions, hydrogen bond, and van der Waals interactions [56] .
Dendrimer-drug conjugates in chemotherapy
Noncovalent encapsulation of drugs can hardly controll the release of payload from the dendrimer core, such as drug leakage in blood circulation, uncontrolled release rate, and so on [50] . Construction of dendrimer-drug conjugates with degradable linkages between the dendrimers and drug by stimuli-cleavable is a promising approach to control the release of drug. On the other hand, only few drugs can take effect without linkage broken [57] [58] [59] . Hydrazone bond is widely utilized for exploiting acid-responsive dendrimer-drug conjugates as prodrugs (Fig. 2a) [60] [61] [62] [63] [64] . The linkage is stable, and can resist hydrolysis in blood circulation (pH 7.4), but degrades in tumor extracellular matrix (pH 6.5-6.8) and accelerates the release of drug after endocytosis into cancer cells (pH 5.0-6.0). Recently, the boronate ester bond was also applied for developing acid-responsive . . . . . . . . . . . . . . . . . . . . . . . . . . . prodrugs (Fig. 2b) [65, 66] , which was more sensitive under pH 6.5 than hydrazone bond and induced fast drug release under tumor extracellular condition.
Disulfide bond was usually employed for development of reduction-responsive dendrimer-drug conjugates, which can be rapidly cleaved by abundant intracellular reduction agent glutathione (GSH) to release free drug [67] [68] [69] . In order to reduce the adverse effects and enhance the therapeutic index, doxorubicin and paclitaxel could be made into GSH-responsive dendrimer-drug conjugates as prodrugs (Fig. 2c) . These dendrimer-drug conjugates show lower toxicity and higher efficacy, compared to free drugs by largely accumulation in tumor tissue [70] [71] [72] [73] .
Enzyme-labile bonds also could be employed for construction of enzyme-responsive prodrugs [74] . Proteases, such as matrix metalloproteinases (MMP) and cathepsin B are unusually expressed in the tumor microenvironment. Some specific sequences peptides can be cleaved by those over-expressed proteases, e.g., collagen peptide is cleavable by abundant MMP-9, and Gly-Phe-Leu-Gly oligopeptide (GFLG) is degradable in the presence of cathepsin B. When the specific peptide like GFLG (Fig.  2d) or collagen (Fig. 2e) is chosen as linkers to construct paclitaxel or doxorubicin prodrug, the specific therapy would be achieved by efficiently killing the cancer cells in tumor tissues and minimizing the toxicity to normal cells [75] [76] [77] .
Light-labile bonds could be employed for light-responsive dendrimer-drug conjugates, which can be rapidly cleaved by external light trigger (e.g., ultraviolet (UV), visible or near-infrared (NIR)) to release free drug. Some specific linkers, such as orthonitrobenzyl (ONB), cleave under UV. The burst release of drugs happens in the presence of UV irradiation, when ONB is chosen as linker to conjugate the dendrimer and chemotherapeutics. These conjugates will minimize the toxicity on normal cells in the dark (Fig. 2f) [78, 79] .
Assembled amphiphilic dendrimers in chemotherapy
Self-assembly of amphiphilic molecules is one of the most commonly phenomena in biological systems [80, 81] . Generally, amphiphilic dendrimers have two structural segments, the hydrophobic and hydrophilic components. Recently, self-assembly of amphiphilic dendrimers into nanocarriers is a promising approach to avoid disadvantages of dendrimer in cancer treatment, such as the uncontrolled drug release and serious toxicity of high generation dendrimers [82] [83] [84] . Particularly, well designed amphiphilic dendrimers could give the nano-vectors a series of special features in cancer therapy.
Wei and coworkers [85] reported a supramolecular nanomicellar carrier based on amphiphilic dendrimer (AmDM), which consisted of one small PAMAM dendrimer as hydrophilic part and two C18 alkyl chains as hydrophobic part. The resulting doxorubicin (DOX) loaded AmDM/DOX nanomicelles possess small size (about 10 nm) and very high drug-loading ability (>40%). AmDM/DOX drug delivery system can effectively improve anticancer efficiency and overcome drug resistance via the combination of enhanced cellular uptake and markedly reduced efflux of the drug. In addition, the AmDM/DOX nanocarriers significantly decrease systemic toxicity compared to the free DOX.
To achieve tumor-specific delivery of antitumor drug, acid-responsive amphiphilic dendrimers were designed. These amphiphilic dendrimers could self-assemble into nanocarriers, and the nanostructures could be disassembled to release drug under a changed hydrophiliclipophilic balance (HLB) in tumor tissue or organelle with specific acidic condition. This disassembly behavior could be triggered by protonation, deprotonation or cleavage of pH-sensitive covalent bonds, such as ketal, boronate ester and hydrazone bonds [84, [86] [87] [88] [89] [90] [91] [92] [93] [94] . Recently, an amide bond formed from 2-propionic-3-methylmaleic anhydride (CDM) was employed to develop newly acid-responsive amphiphilic dendrimers, which cleaved under tumor extracellular acid environment (pH ∼6.5-7.2) [95] . Li and coworkers [96] synthesized an amphiphilic dendrimer PCL-CDM-PAMAM/Pt and co-assembled with PEG-b-PCL and PCL to prepare pH-sensitive clustered NP (iCluster) by nanoprecipitation method. This iCluster could overcome systematically a series of barriers by sequentially reacting in the tumor microenvironment. At physiological pH, iCluster hold a particle size about 100 nm, which was helpful for long blood circulation and tumor tissue accumulation through the EPR effect. When iCluster heaps at tumor sites, the tumor extracellular acidic condition triggers the release of platinum prodrug PAMAM/Pt (diameter around 5 nm) that greatly improves tumor penetration and cell internalization. The internalized PAMAM/Pt would be further reduced to release free cisplatin to eliminate cancer cells. The superior in vivo antitumor effect of iCluster also has been validated in various tumor models, which indicates this acid-responsive amphiphilic dendrimer facilitates overcoming systematically multilevel barriers to improve delivery efficacy and reduce adverse effects of drug.
Redox-responsive amphiphilic dendrimers based on disulfide bond are efficient drug carriers in tumor treatment. Shao and coworkers [97] proposed an amphiphilic dendrimer (named as telodendrimer), which was composed of dendritic polylysine, linear PEG and specific peripheral groups. Telodendrimer could self-assemble into nanocarriers and be disassembled via the responsiveness of the built-in disulfide cross-linker to the redox tumor microenvironment for controlled drug release and efficient drug delivery in vivo. Recently, Li and coworkers [98] designed lipoic acid (LA)-functionalized amphiphilic dendrons and PEG derivatives, which could self-assemble into supramolecular dendritic systems (TSPDSs) for efficient platinum delivery. This supramolecular dendritic system is able to stably exist by bio-reducible disulfide bonds and PEGylated platinum derivatives could coordinate with peripheral carboxyl of dendritic systems for tumor treatment. TSPDSs obviously improve the biodistribution and pharmacokinetics of platinum, due to the PEGylated shell and stable nanostructure in the blood circulation. High glutathione concentration of tumor intracellular environment could lead to the rapid disassembly of TSPDSs due to redox-cleavable disulfide bonds, and then platinum is transported into the nuclei to play antitumor role. Compared to clinical cisplatin, TSPDSs have higher antitumor efficiency and lower renal toxicity.
Enzyme-induced drug release via enzyme-sensitive chemical bond cleavage is a strategy to design enzymeresponsive NPs based on amphiphilic dendrimers for tumor therapy. A PEGylated amphiphilic peptide dendritic-drug conjugate is constructed via antitumor drug conjugated to the periphery of dendrimer by an enzymeresponsive linker and could self-assemble into enzymesensitive anti-cancer NPs. Owing to the on-off demand of drug and the nanoscale size, the in vivo antitumor efficacy of these enzyme-sensitive NPs is verified with reduced side effects [99] [100] [101] . Enzyme-responded hydrophilic-lipophilic balance (HLB) disruption is another strategy to construct enzyme-responsive materials. Amphiphilic dendrimer composed of enzyme-sensitive dendrons could self-assemble into nanocarriers that disassemble to release drug under action of enzymes [102] .
Light-induced HLB disruption also is a strategy to design light-responsive amphiphilic dendrimers. Sun and coworkers [103] designed diazonaphthoquinone-modified amphiphilic PAMAM dendrimers, which could assemble into DNQ-cored micelles in aqueous solutions. Irradiated by NIR light, the micelles will produce an HLB change in the supermolecular system, which leads to the disassembly of the micelles and a quick release of the loaded DOX. The NIR-responsive amphiphilic dendrimer nanomedicine shows great potential for controlled drug delivery.
Multistimuli-responsive delivery system is a more effective strategy in drug delivery for combating tumor [104, 105] . Li and coworkers [106] designed tumor-specific multistimuli-responsive nanoassemblies with a metabolic barrage to completely overcome both physiological and cellular barriers of multidrug resistance (Fig. 3) . The nanoassemblies were self-assembled from amphiphilic dendrimers which consisted of tumor microenvironment MMP sensitive peptides (GPLGLAG sequence) to discharge hydrophilic PEG parts, cytoplasmic redox-labile disulfide bonds between peptide dendrons, and lysosome acid-breakage hydrazone bonds for linking antitumor drugs DOX. Impressively, the nanoassemblies could hierarchically overcome the serial barriers of drug resistance, including PEGylated corona to extend blood circulation, the nanostructures for large tumor accumulation by EPR, enzyme-sensitivity to enhance tumor penetration and cellular uptake, redox-active discharge for effective release of DOX, and lysosome acid-responding nucleus delivery of DOX. Simultaneously, several drug resistance pathways were restrained by these nanoassemblies. Ultimately, the nanoassemblies were found to inhibit 84% drug-resistant MCF-7R tumor in vivo, compared to 32% tumor growth inhibition accomplished by free DOX·HCl treatment.
Dendrimer nanohybrid carriers in chemotherapy
Dendrimer and other nano-vehicles-based hybrid carrier is another strategy for drug delivery [107] . Compared to some conventional nanocarriers, dendrimers have a smaller size, which can be easily loaded or conjugated to construct nanohybrid carriers with enhanced antitumor efficiency. Conventional NPs could make for accumulation at tumor tissue depending on the EPR effect, but they have poor deep penetration capacity into tumor tissues for uniform distribution. Fan and coworkers [108] designed a multistage nanocarrier by anti-tumor model drug methotrexate (MTX) loaded on PAMAM dendrimers encapsulated in gelatin NPs. This nanohybrid carrier was stable during systemic circulation and largely accumulated in tumor tissue via EPR effect. In the tumor microenvironment, PAMAM dendrimers were released from these nanohybrid carriers in response to MMP-2 enzymes and penetrated deeply into tumor tissue due to smaller size. Sun and coworkers [109] thought the synergistic effect between the components of nanocarriers with various functions could enable them to complete the circulation-accumulation-internalization-penetration-release (CAPIR) cascade and achieve high therapeutic efficacy, and thus they designed nanohybrid carriers using DOX loaded PAMAM dendrimers encapsulated in liposome (Fig. 4) . These nanohybrid carriers could complete the role of prolonging blood circulation and enhance tumor accumulation, while its "bomblets", DOX loaded PAMAM dendrimers with smaller size (<5 nm) complete the task of tumor penetration and cell internalization. Remarkably, the nanohybrid carriers could overcome the membrane-associated drug resistance and uptake DOX into drug-resistant cell. Ultimately, in-vivo therapeutic efficacy of the nanohybrid carrier had 85% tumor inhibition rate in drug-resistant MCF-7 tumor.
Dendrimers with inherent activity in chemotherapy
Recently, therapeutic dendrimers as a new type of efficient chemotherapy drugs have been reported. Zhang and coworkers [110] designed the bioinspired tryptophanrich peptide dendrimers (TRPDs) as a chemotherapy drug for efficient tumor treatment (Fig. 5a) . The tryptophan-rich dendrimeric structures of TRPDs significantly induced supramolecular interactions with DNA. Most importantly, TRPDs showed excellent cytotoxicity against various tumor cells by strong membrane permeability and prominently disturbed the cell cycle. Further experiment showed that the TRPDs also restrained the proliferation and boosted apoptosis of cancer cell in vivo. Shao and coworkers [111] reported a polyacylthiourea dendrimer G4 polyacylthiourea (PATU), which had inherent potent anticancer activity and the absence of cytotoxicity in mice (Fig. 5b) . The anticancer activity of G4 PATU in vivo was from the exhaust of bioavailable copper, the subsequent suppression of angiogenesis and cell proliferation. Remarkably, compared to DOX, this dendrimer could efficiently inhibit multidrug resistance (MDR) and tumor metastasis, with no-cytotoxin induced side effects.
GENE THERAPY
Gene therapy is a promising option for the treatment of cancers [112] [113] [114] . However, few safe and efficient gene vectors for the delivery of DNA and siRNA limit the development of clinical gene therapy. Cationic den- . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . REVIEWS drimers, which possess cationic groups on the surface and peripheral multivalency, can bind nucleic acids for efficient condensation and intracellular delivery [45, 46] .
Traditional dendrimer/nucleic acid complexes in gene therapy
The definite number of amine groups on the surface of dendrimer can efficiently condense DNA or siRNA into nanocarriers (dendriplexes) by electrostatic interaction and avoid their degradation by enzymes [115] [116] [117] [118] . Then, the formed nanocarriers can be internalized into cells and localized in endosomes or lysosomes. In addition, plenty of tertiary amine groups of dendrimers can facilitate the endosomal escape of dendriplexes via a "proton-sponge" mechanism [115, 119, 120] [130] first reported that PAMAM dendrimers as non-viral gene vectors could efficiently express luciferase in cultured cell and found that Generation 6 (G6) PAMAM dendrimer had maximal gene transfection efficiency among G1 to G10 PAMAM dendrimers. Different generations of dendritic PLL were synthesized by Luo and colleagues, they found that G5 PLL complexes with plasmid DNAs showed the higher gene transfection than other dendrimers similar to PEI, but with lower cytotoxicity [131] . Disulfide cross-linked low generation (G2) PAMAM dendrimers were constructed as highly efficient gene carriers, which could avoid high cost and serious cytotoxicity of high generation dendrimers [132] . Cationic dendrimers are not only able to effectively deliver plasmid DNA but also siRNA to silence the heat shock protein 27, resulting in a prominent anticancer effect in prostate cancer model [133, 134] .
Dendrimer conjugates in gene therapy
The effects of traditional dendrimers in gene transfection are not desirable, which are usually blocked by poor transfection efficacy and serious cytotoxicity [45] . Modifying dendrimers with various functional groups or introducing degradable linkages by stimuli-cleavable bonds to construct dendrimer conjugates for gene delivery may be a promising task to improve gene transfection effect.
Dendrimers modified with alkaline amino acid (such as arginine, histidine and lysine) can improve the transfection efficacy (Fig. 6) . Positively charged groups in alkaline amino acid can evidently increase the charge density of dendrimer surface, which is beneficial for DNA condensation and polyplex stability [135] . Guanidinium group of arginine shows stronger interaction with phosphates in DNA and cell membrane [136, 137] . Histidine modified dendrimer can improve endosomal escape and the serum-resistance resulting from the imidazole group in the structure [138] . As a result, alkaline amino acidmodified dendrimer conjugates were widely used as efficient vectors for DNA and siRNA during the past decade [131, .
Cancer cell-specific receptor modified dendrimer conjugate can achieve the targeted gene delivery via ligandreceptor or antibody-antigen interaction. For example, epidermal growth factor receptors (EGFR) modified dendrimer conjugate can increase transfection efficiency of pDNA in liver cells 10-fold compared to the unmodified ones [161] . Antibody anti-CD71-modified PA-MAM dendrimer shows much higher cellular uptake and more efficient antiapoptotic gene silencing in prostate cancer cells compared to no-antibody ones [162] . Transferrin-conjugated dendrimers can highly express tumor necrosis factor α (TNFα) by delivery of plasmids in prostate cancer cells in vitro and in vivo [163] . Major histocompatibility complex (MHC) class II-targeting peptides modified dendrimers can deliver DNA-based vaccines to specifically accumulate in professional antigen-presenting cells, which enhances immunostimulatory potency and provides an immunotherapy for tumor treatment [164] .
Dendrimers modified with acid-responsive groups can also increase the transfection efficacy. Shen and coworkers [165] constructed acid active peptide pHLIP-conjugated PLL dendrimer to inhibit tumor growth by REVIEWS . . . . . . . . . . . . . . . . . . . . . . . . . . SCIENCE CHINA Materials   1410 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . enhanced expression of siRNA targeting vascular endothelial growth factor. This dendrimer conjugate can weakly interact with cell membrane in physiological environment, whereas it can enhance gene internalization via a transmembrane α-helix forming from pHLIP at tumor acidic microenvironments (Fig. 7) . Benns and colleagues [166] developed a pH-sensitive dendrimer conjugate PLH-g-PLL, which improved transfection by excellent membrane fusion at endosomal pH values and enhanced endosomal release of DNA.
Dendrimer conjugates containing disulfide bonds as gene carriers can improve the transfection efficacy. The spermine groups are conjugated to the dendritic scaffold of dendrimer via a disulfide linkage, which can easily be discharged by intracellular GSH. Owing to the weak affinity towards DNA of spermine groups, these reductionresponsive carriers show a controlled release of spermine groups and DNA [167] . Introducing disulfide bonds between dendrimer and a cell-binding ligand also can improve transfection effect. The ligand can enhance complex accumulation in the target cell, and further the carriers can release nucleic acids in an intracellular reduction-responsive manner [168] .
Amphiphilic dendrimers in gene therapy
Amphiphilic dendrimers with hydrophilic and hydrophobic domains are able to form multivalent delivery systems for gene therapy. Lipid compounds such as fatty acids and cholesterol are always chosen as the hydrophobic parts. Lipids have strong fusogenic activity, which can improve cellular uptake and endosomal escape of polyplexes for effective transfection [169] . Amphiphilic dendrimers show the combined advantages of lipid and dendrimer for high-efficiency and safe gene delivery, which can be constructed by conjugation of lipids to the core or surface of dendrimer.
In general, high generation dendrimers with the high density positive charges facilitate the stability and internalization of polyplexes into cells [115] . However, extra positive charges of polyplex may induce increased cytotoxicity [170] . Amphiphiles formed from conjugation of lipids to the core of low-generation dendrons, can selfassemble into micelles for safe and efficient gene delivery. In the early stages, PLL modifed with three dodecanoyl chains can achieve self-assembly and effective gene delivery (Fig. 8a) [171] . Yu and colleagues [172] constructed a series of amphiphilic PAMAM dendrimers with various alkyl chain length and dendron structure as siRNA vectors. They found that the vector bearing a C18 alkyl chain and a PAMAM dendron with third-generation structure, was able to transport Hsp27 siRNA and induce significant gene silencing against a castration-resistant cancer (Fig.  8b) . G1 PAMAM conjugated with two alkyl chains such as unsaturated octadecyl (DL-G1-2C18) (Fig. 8c) and saturated octadecenyl (DL-G1-2C18-U2) (Fig. 8d) show much improved gene transfection efficacy. Particular, DL-G1-2C18-U2 presents more efficient transfection on HeLa cells compared to DL-G1-2C18. The results indicate that the unsaturated chains for the amphiphilic dendrimers with excellent gene transfection are very important [173] . Amphiphilic dendrimers having the same octadecyl chains but different generation of dendron parts show different transfection activity (Fig. 8e) [174] . Multivalent amphiphiles, which have a C18 alkyl chain in the core and a second-generation dendrimer (G2-octaamine, 4) with four glycine arrays on the surface, can be a safe and efficient carrier to transport siRNA and acquire effective gene silencing in HeLa cells (Fig. 8f) [175] . Selfassembling the defined arginine-containing amphiphilic dendritic lipopeptides for virus-inspired nanocarriers can greatly enhance transfection efficiency and reduce cytotoxicity in HepG2 cells (Fig. 8g) [176] .
Conjugation of lipids to the periphery of dendrimer can also improve the efficacy of transfection. PAMAM dendrimers conjugated with different length alkyl chains can achieve efficient DNA delivery. The presence of alkyl chains obviously increases the cellular uptake of polyplexes and the effect is positively correlated with the length. However, the smallest hydrophobic chains show the higher efficiency due to effortless DNA release. Similarly, PPI dendrimer modified with alkyl chains of suitable length increases 60-fold transfection efficiency than the unmodified one [177] . Cholesterol and alkyl chains modified G2 PAMAM dendrimers are also benefit for gene transport, including excellent low cytotoxicity, serum-resistance, and efficient transfection. Among these dendrimers, G2 PAMAM dendrimer modified with a saturated C18 alkyl chain exhibits the highest transfection efficacy [178] .
Stimuli-responsive amphiphilic dendrimers can be designed for effective gene delivery. Tschiche and coworkers [179] designed an amphiphilic dendrimer, which is composed of a lipoic acid-derived dendron structure and had the ability to self-assemble into supramolecular nanostructure. The redox-triggered disassembly leads to faster siRNA release and higher transfection efficiencies for gene silencing compared to noncrosslinked ones. Similarly, conjugating a disulfide bond to the surface of the core lipid-functionalized PLL dendrimer results in highefficiency RNA interference and low toxicity in vivo [180] . Recently, Liu and coworkers [181] proposed an amphiphilic dendrimer bola4A, which introduces a reactive oxygen species (ROS)-activatable thioacetal group in hydrophobic part and two PAMAM dendrons as the peripheral groups. Bola4A could compact siRNA into nanostructure to enhance cellular uptake and efficiently disassemble under the response of the built-in thioacetal linker in ROS-rich tumor cells for effective gene delivery and silencing.
Dendrimer nanohybrid carriers in gene therapy
Dendrimer nanohybrid carriers, which are constructed by dendrimer grafting onto NPs, such as quantum dots, carbon nanotubes, magnetic NPs, gold NPs, are widely used in gene delivery with enhanced transfection efficiency and reduced cytotoxicity compared to unmodified ones.
For example, Xu and coworkers [182] designed a functionalized low generation peptide dendrimer, which could self-assemble onto the surface of quantum dots to prepare multifunctional supramolecular hybrid dendrimers. These hybrid dendrimers show 50,000-fold higher gene transfection efficiency than single low generation peptide dendrimer and real-time tumor fluorescent signaling properties (Fig. 9a) .
PAMAM dendrimers are grafted onto gold nanorods for delivering short hairpin RNA (shRNA) into breast cancer cells (Fig. 9b) . These conjugates also can be used to kill cancer cells by synergetic photothermal ablation role via NIR light irradiation [183] . In addition, PAMAM dendrimers encapsulating gold NPs also exhibits much improved gene transfection efficacy and reduced cyto- REVIEWS . . . . . . . . . . . . . . . . . . . . . . . . . . SCIENCE CHINA Materials   1412 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . toxicity on several cancer cells [184] [185] [186] [187] .
Fe 3 O 4 nano-worm is modified with PAMAM dendrimers and utilized for siRNA delivery (Fig. 9c) , which obviously promotes endosomal escape and suppresses the EGFR protein expression in glioblastoma in vivo [188] . Similarly, ternary magnetoplexes polyplexes containing PAMAM dendrimer-modified magnetic iron oxide greatly improve the transfection efficiency [189] .
CONCLUSIONS AND PERSPECTIVES
Dendrimer-based NPs are emerging as a promising delivery system in cancer chemotherapy and gene therapy due to their well-defined nano size, 3D hyperbranched structure, and globular architecture. The dendritic scaffolds provide hydrophobic interior to load drug, while the periphery can link multifunctional surface groups for diverse applications. The unique features of tumor microenvironment also can be used to explore the active targeting or stimuli-responsive dendrimer based NPs to enhance therapeutic effect and reduce the toxic effect. There are several structures usually adopted in the design of dendrimer-based delivery systems, such as non-modified dendrimers, dendrimer conjugates, assembled amphiphilic dendrimers, nanohybrid dendrimer carriers and dendrimers with inherent activity. Although dendrimerbased NPs are effective against some cancers by single chemotherapy or gene therapy, the successful anticancer treatment is frequently impeded by MDR or tumor metastasis. Therefore, to take full advantage of dendrimers to develop the various combinations of chemotherapy and gene therapy, successful antitumor therapy may be achieved by overcoming MDR and inhibiting tumor metastasis. In addition, despite the numerous advantages of dendrimers as drug/gene carriers, most of them are limited by the implementation of concept and high cost for clinical applications. Therefore, researchers should pay attention to the complexity of in vivo environments and monitoring cost to reduce these problems and ensure clinical usefulness. 
